The government shutdown is over, but what did it mean for health care and what's coming next? In this episode, the team breaks down the immediate impacts of the shutdown on Medicare and Medicaid claims processing, why healthcare providers were particularly vulnerable, and what's actually in (and notably missing from) the compromise funding deal that reopened the government. Our panel explores the political chess game that led to the shutdown, including Democrats' push for enhanced Premium Tax Credits that didn't make it into the final agreement. We discuss which critical healthcare policies got extended—including telehealth flexibilities, GPCI floors, Hospital at Home waivers, and Medicaid DSH cut delays—and what the claims reprocessing means for providers.

It's 11 PM on a Friday night, and you just received a portal notification: your test results suggest cancer. Your doctor won't be available until Monday. This is the unintended consequence of well-meaning federal rules designed to give patients faster access to their health information. In this episode, the AMGA public policy team explores the Cures Act's "information blocking" provisions and why immediate test results—delivered without context, counseling, or compassion—are causing real harm. From miscarriage notifications via text alert to cancer diagnoses released over the weekend, we examine the collision between technology and patient care. Four years after AMGA first raised concerns, we're still advocating for a middle ground that honors both patient access and quality care delivery.

Is $50 billion enough to save rural healthcare? In this episode, the AMGA team dives deep into the Rural Health Transformation Fund—a program born from the One Big Beautiful Bill Act that promises up to $500 million per state over five years. But there's a catch: the same legislation cuts almost $1 trillion from Medicaid over the next decade. Join the AMGA public policy team as we unpack what this means for rural hospitals on the brink of closure, the communities they serve, and why funding rural healthcare isn't just a rural problem. We'll explore the application requirements, the real impact of Medicaid cuts, and what Secretary Kennedy might prioritize as states compete for these critical funds.

The team sits down with incoming AMGA Chair Beth Averbeck to discuss her experience with palliative and hospice care, from both a clinical and policy perspective. Ensuring patient dignity and wishes at end of life presents a number of policy challenges, and Dr. Averbeck and the team discuss possible solutions.

In Season #2 Episode 8, the AGMA team discussed how the government shutdown is affecting healthcare. The team discussed how the shutdown is disrupting telehealth and hospital-at-home programs, how AMGA members are responding to the shutdown, and what the key political sticking points preventing a resolution are. Additional details and all episodes are available on the AMGA website.

In Season #2, Episode #7: The AMGA team discusses our regulatory priorities and how outdated regulations and rules hinder care and create administrative burden. The team compared some of them to “microwaving fish” in the staff break room. The team explained how Medicare rules and regulations can be updated, so they support care modern care delivery systems. Additional details and all episodes are available on the AMGA website.

In Season #2, Episode #6: The AMGA team discusses the government shutdown and the ramification for AMGA members. The team explain that while Medicare will continue to pay claims, several key healthcare flexibilities, such as telehealth, expired and need to be reauthorized. Additional details and all episodes are available on the AMGA website.

In Season #2, Episode #5: The AMGA team discusses the importance of developing relations with congressional staff and providing real-world experience and expertise. The team explains how offering concrete policy recommendations will go a long way to achieving policy aims. Additional details and all episodes are available on the AMGA website.

With another government shutdown looming, the AMGA team explains how the appropriation process is supposed to work, in the context of a viral TikTok trend.

HRSA’s new 340B model will test a rebate model for 340B drugs, requiring providers to file for a rebate rather than receiving an upfront discount. The AMGA discusses the ramifications of this change, along with CMS’ plan to accelerate a repayment plan as part of its proposed outpatient rule.